Immuron's IMM-124E shows encouraging action in mid-stage NASH study; shares ahead 81% [Seeking Alpha]
Immuron Limited - American Depositary Shares (IMRN)
US:NASDAQ Investor Relations:
immuron.com/investor-centre/business-overview
Company Research
Source: Seeking Alpha
Immuron's IMM-124E shows encouraging action in mid-stage NASH study; shares ahead 81%Thinly traded nano cap Immuron Limited (IMRN+81.4%) is up on a 13x surge in volume, albeit on turnover of only 148K shares, on the heels of itsannouncement of positive results from aPhase 2 proof-of-concept clinical trialassessing IMM-124E in 133 NASH patients, a reversal of fortune for the company after it reported unsuccessful results in July.Top-line data showed treatment with IMM-124E (bovine colostrum) produced a statistically significant reduction in serum lipopolysaccharide (LPS) levels compared to placebo. LPS is associated with the progression of NASH. Specifically, 64.3% of patients in the treatment group experienced at least a 15% decrease in serum LPS versus 34.5% for placebo (p=0.018).36.4% of patients receiving the higher dose (1200 mg) of IMM-124E experienced at least a 30% drop in average serum ALT (enzyme biomarker for liver damage) compared to 13.6% for placebo (p value not reported)
Show less
Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMRN alerts
High impacting Immuron Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMRN
News
- We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
- Immuron Presentation Australian Biologics Festival 2024GlobeNewswire
- Immuron achieves record Travelan® sales [Yahoo! Finance]Yahoo! Finance
- Immuron achieves record Travelan® salesGlobeNewswire
- Immuron CEO, Steven Lydeamore Investor Webinar Presentation [Yahoo! Finance]Yahoo! Finance
IMRN
Sec Filings
- 3/14/24 - Form 6-K
- 3/5/24 - Form 6-K
- 2/28/24 - Form 6-K
- IMRN's page on the SEC website